65438 On February 22, 2022, Cube Pharmaceutical announced that it planned to introduce investors to its wholly-owned subsidiary Cube Pharmaceutical by way of capital increase. The investor is China Resources Runyao, a subsidiary of China Resources Pharmaceutical Co., Ltd., which sells shares of Cubic Pharmaceutical Co., Ltd. with a share ratio of more than 5 1%.
Cube Pharmaceutical said that in recent years, the head effect of the pharmaceutical circulation industry has been obvious. The market share of large domestic pharmaceutical circulation enterprises, such as Sinopharm Holdings, China Resources Pharmaceutical and Shanghai Pharmaceutical Holdings, is constantly expanding, and the industry competition is fierce, which requires huge capital investment. Therefore, the company intends to sell the control of pharmaceutical wholesale assets through this transaction.
After the transaction is completed, the company will withdraw from the third-party product distribution business in the pharmaceutical business sector and retain the original research and development, manufacturing and self-operated business of modern Chinese medicine and chemicals.
Development course of China Resources:
1983 (the year of Guihai), China Resources reorganized its subsidiaries into companies with equity as the link, and on this basis, China Resources (Group) Co., Ltd. was established.
Since then, the business of China Resources has changed from general agency trade to self-management, and through a series of industrialization investments, it has gradually developed into an influential enterprise group with industrialization as its core in Hong Kong and the Mainland. In 20 13 years, China resources group ranked among the top 500 in the world 143.
China Resources Group has seven strategic business units, 19 first-class profit centers, more than 2,300 entity enterprises and 400,000 employees (2065,438+065,438+0 year data: 7 S buses, 2/kloc-0 first-class buses, 1 entity enterprises with employees. China Resources has five listed companies in Hong Kong and six listed companies in the Mainland.
Baidu Baike-China Resources (Group) Co., Ltd.